Life Sciences: Corporate/Commercial
USA
5 years ranked
Life Sciences: Corporate/Commercial
USA
5 years ranked
Capital Markets: Debt & Equity: Western United States
USA
4 years ranked
Provided by Gibson, Dunn & Crutcher LLP
Co-chair, global life sciences practice, Ryan focuses on representing operating companies and investors in the biotechnology, pharmaceutical, diagnostics and medical device industries in connection with securities offerings, corporate governance matters and business combination transactions. He serves as principal outside counsel for publicly-traded companies and venture-backed companies, advising management teams and boards of directors on general corporate matters, securities offerings, SEC reporting, corporate governance, royalty financings and mergers & acquisitions. He also advises investment funds (private equity funds, hedge funds, venture funds and royalty buyout funds) in connection with investments in life sciences companies and assets.
Provided by Chambers
Provided by Chambers
He's a technical lawyer who has got a fantastic capital markets practice.
Chambers is the leading data and intelligence partner for the legal sector.